Docs push for new COVID-19 funding as signs point to rebound in U.S. omicron cases
By
Alicia Lasek
Mar 17, 2022
The alternative is to risk leaving patients without access to needed vaccines, treatments and testing, the American College of Physicians has told Congress.
Fed’s booster OK too late? Nursing home loses 8 to coronavirus outbreak this fall
By
Alicia Lasek
Nov 17, 2021
A Connecticut nursing home has weathered a facility-wide COVID-19 outbreak that has sickened 89 residents and staff. Booster shots were not yet authorized when the first cases appeared, the operator reports.
Valid dementia verdict? Nursing home and hospital diagnoses now better aligned, study finds
By
Alicia Lasek
May 03, 2021
Medicare’s dementia claim measures appear to have become more sensitive in recent years, agreeing more closely with hospital-based measures overall and for certain populations than in the past, investigators...
FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
Generic for Viagra holds promise as Alzheimer’s disease treatment, Cleveland Clinic researchers say
Dec 08, 2021
Users of sildenafil are 69% less likely to develop Alzheimer’s disease than their peers who do not use the drug, investigators report. A clinical trial to confirm its benefits for Alzheimer’s patients...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
Lawmakers push FDA to take swift action on OTC hearing aids
By
Diane Eastabrook
Apr 12, 2022
A bipartisan team has introduced a bill that orders the FDA to stop dragging its feet and issue a final rule making over-the-counter hearing aids available to consumers.
Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.
‘Already skeptical’ nursing home workers may need persuading after J&J shots resume, industry leaders...
By
Danielle Brown
Apr 26, 2021
Now that vaccinators are encouraged to resume giving Johnson & Johnson’s COVID-19 shot, nursing home stakeholders are questioning what effect the recent pause will have on vaccine uptake in a wary population.
SNF residents avoid repeat hospitalization with nurse-led heart failure program
By
Alicia Lasek
Sep 03, 2021
Sixty days after admission, patients in the disease management program had a lower composite rate of rehospitalization, ED visits or mortality when compared with their peers who had usual care. The program...